Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Bone Marrow Failure Syndromes (aplastic anemia, MDS and PNH) BMT vs. non transplant immunosuppressive therapies

    ... to as hematopoietic stem cell transplant ) using peripheral blood and if bone marrow is an option for patients with aplastic anemia ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  2. Bone Marrow Failure Syndromes (aplastic anemia, MDS and PNH) BMT vs. non transplant immunosuppressive therapies

    ... to as hematopoietic stem cell transplant ) using peripheral blood or bone marrow is an option for patients with aplastic anemia , ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  3. Bone Marrow Transplant for MDS and Other Bone Marrow Failure Diseases: Before, During and After

    ... A hematopoietic stem cell transplant by using peripheral blood or bone marrow is an option for many people with aplastic ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  4. Bone Marrow Transplant for MDS and Other Bone Marrow Failure Diseases: Before, During and After

    ... A hematopoietic stem cell transplant by using peripheral blood or bone marrow is an option for many people with aplastic anemia ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  5. Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    ... following donor types identified who are willing to donate peripheral blood: a. Related donor, 8/8 HLA -matched for HLA-A, -B, C and DR ...

    Clinical Trial last updated 06/06/2016 - 12:41pm.

  6. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... in enhancing engraftment following umbilical cord blood transplantation (recovery of blood counts after transplant). ... lymphoma, transformed lymphoma, mantle cell lymphoma, and peripheral T cell lymphoma, who also have one of the disease features ...

    Clinical Trial last updated 06/06/2016 - 3:37pm.

  7. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    ... Related donor must weigh > 25.0 kg., must have adequate peripheral venous catheter access for leukapheresis or must agree to placement ... and (2) receive G-CSF followed by donation of peripheral blood stem cells (product to be determined by randomization post ...

    Clinical Trial last updated 06/06/2016 - 1:36pm.

  8. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... Table 2.4a) Patients must have a related or unrelated peripheral blood stem cell donor as follows: Sibling donor must be a 6/6 match for ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  9. Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies

    ... chemotherapy treatment. The NK cells will be separated from blood from a relative of yours or from umbilical cord blood. These separated NK ... Patients must have less than 20% bone marrow or peripheral blood blasts . Acute myeloid leukemia in first remission ...

    Clinical Trial last updated 06/06/2016 - 1:18pm.

  10. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... in enhancing engraftment following umbilical cord blood transplantation (recovery of blood counts after transplant). ... lymphoma, transformed lymphoma, mantle cell lymphoma, and peripheral T cell lymphoma, who also have one of the disease features ...

    Clinical Trial last updated 06/03/2016 - 2:54pm.